Report LibraryAll Reports
Datamonitor Healthcare CNS: Attention Deficit Hyperactivity Disorder (ADHD) Market Spotlight
Retail Price: $2,995.00*BioMedTracker Subscriber Price: $2,095.00 - click here to log in
August 08, 2018Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders, affecting approximately 2.2–7.2% of children and adolescents, and 2.8–5.0% of adults globally. The condition is characterized by persistent inattention, hyperactivity, and/or impulsive behavior that is more severe and more frequent than that typically observed in individuals of a similar developmental stage. This results in functional impairment in areas such as cognition, social interaction, employment, self-care, and mobility. The disorder is often diagnosed in early childhood, although recent studies have highlighted the potential for late-onset and even adult-onset ADHD. Due to its high prevalence, strong correlation with subsequent psychiatric co-morbidities, persistence into adulthood, and functional impairment across the life course, ADHD is now being recognized as an important disorder worldwide.
This Datamonitor Healthcare report contains a Market Spotlight module.
|Disease Group Covered:||Psychiatry|